Survey of Pass/Fail Grading Systems in US Doctor of Pharmacy Degree Programs

被引:0
|
作者
Spiess, Joel P. [1 ]
Walcheske, Erin [1 ]
MacKinnon, George E., III [1 ]
MacKinnon, Karen J. [1 ]
机构
[1] Med Coll Wisconsin, Sch Pharm, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA
关键词
pass/fail; grading; assessment; pharmacy student; residency; MEDICAL-STUDENTS;
D O I
暂无
中图分类号
G40 [教育学];
学科分类号
040101 ; 120403 ;
摘要
Objective. To understand how US schools and colleges of pharmacy use pass/fail grading systems in Doctor of Pharmacy degree programs. Methods. An electronic survey with 15 selected response items and six open-ended questions was developed to gather qualitative and quantitative data. The convenience survey was distributed in 2020 to the 10 academic pharmacy programs known to use a pass/fail grading system for the majority of their courses. Results. Leaders from eight of the 10 programs identified responded to the survey. Programs varied regarding the types of courses for which they used a pass/fail grading system and whether they shared numerical scores with their students. A variety of grade designations (honors, pass, no pass, fail, satisfactory, etc) were used, and the minimum pass level varied by program, ranging from 70% to 90%. For those institutions that used post-course remediation, the majority of remediation occurred immediately following the academic term or in the summer. The type of information shared with residency program directors (eg, GPA, class rank, overall percentile, qualitative comments) varied between programs. Conclusion. How pass/fail grading systems were used was inconsistent across the cohort. Programs that use a criterion-based grading system might benefit from engaging in conversations with other schools that do the same to determine whether and how consistency in terminology, passing level, percentages, grade point averages, and progression might be achieved. Additional insights on postgraduate training requirements and honorary societies are warranted should the use of pass/fail grading expand as it has in medical education. Further research on this topic is needed.
引用
收藏
页数:4
相关论文
共 26 条
  • [21] Results of a National Survey of Program Directors' Perspectives on a Pass/Fail US Medical Licensing Examination Step 1
    Patel, Om U.
    Haynes, William K.
    Burge, Kaitlin G.
    Yadav, Ishant S.
    Peterson, Todd
    Camino, Andres
    Van Wagoner, Nicholas J.
    [J]. JAMA NETWORK OPEN, 2022, 5 (06)
  • [22] Accessibility of postgraduate training program information to graduates from US doctor of pharmacy programs holding F-1 visas
    Lu, Chi-Hua
    Rauf, Maha
    Wasim, Ume Farwa
    Zhang, Qiuyi
    Prescott, Gina M.
    Slazak, Erin M.
    Desai, Kalpesh J.
    Bednarczyk, Edward M.
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2022, 79 (01) : E50 - E57
  • [23] A Survey of Otolaryngology Residency Programs on Adapting to the United States Medical Licensing Examination (USMLE) Step 1 Transitioning to Pass/Fail
    Yang, Lydia C.
    Bonner, Andrew
    Patel, Om U.
    Haynes, William
    Burge, Kaitlin
    Yadav, Ishant
    Van Wagoner, Nicholas J.
    Greene, Benjamin J.
    Grayson, Jessica W.
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (09)
  • [24] A Cross-Sectional Survey Study Examining the Provision of Continuous Glucose Monitoring Education in U.S. Doctor of Pharmacy Programs
    Knezevich, Emily
    Fuji, Kevin T. T.
    Larson, Krysta
    Muniz, Gabrielle
    [J]. PHARMACY, 2022, 10 (06)
  • [25] PASS-FAIL AS EVALUATION CATEGORIES IN EXAMINATIONS - SURVEY OF EMPIRICAL RESULTS CONCERNING COMPARISON BETWEEN STRONGLY AND WEAKLY DIFFERENTIATED EVALUATION SYSTEMS
    VIEBAHN, P
    [J]. PSYCHOLOGIE IN ERZIEHUNG UND UNTERRICHT, 1977, 24 (04): : 231 - 240
  • [26] Evaluation of β-lactam therapeutic drug monitoring among US health systems with postgraduate year 2 infectious diseases pharmacy residency programs
    Chen, Chieh
    Seabury, Robert W.
    Steele, Jeffrey M.
    Parsels, Katie A.
    Darko, William
    Miller, Christopher D.
    Kufel, Wesley D.
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2022, 79 (15) : 1273 - 1280